The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.
暂无分享,去创建一个
Desmond E. Williams | S. Saydah | T. Hoerger | X. Zhuo | Thomas J Hoerger | Sean A. Simpson | B. Yarnoff | M. Pavkov | N. Ríos Burrows | Desmond E Williams | Xiaohui Zhuo | Meda E Pavkov | Sean A Simpson | Benjamin O Yarnoff | Nilka Ríos Burrows | Sharon H Saydah | Meda E. Pavkov
[1] M. Engelgau,et al. Changes in incidence of diabetes in U.S. adults, 1997-2003. , 2006, American journal of preventive medicine.
[2] Haifeng Guo,et al. US Renal Data System 2012 Annual Data Report. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] Rury R Holman,et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). , 2003, Kidney international.
[4] Desmond E. Williams,et al. Cost-effectiveness of screening for microalbuminuria among African Americans. , 2012, Journal of the American Society of Nephrology : JASN.
[5] N. Powe,et al. Screening for Proteinuria in US Adults , 2017 .
[6] Essam Elsayed,et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] Foreman,et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. , 2013, JAMA.
[8] Jerry Yee,et al. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[9] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[10] B. Astor,et al. Age and association of kidney measures with mortality and end-stage renal disease. , 2012, JAMA.
[11] Michael M. Engelgau,et al. Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.
[12] Desmond E. Williams,et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[14] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[15] Charles E. McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[16] Martin Krapcho,et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .
[17] E. Arias,et al. United States life tables, 2005. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[18] L. Goldman,et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. , 1997, JAMA.
[19] J. Coresh,et al. Lifetime incidence of CKD stages 3-5 in the United States. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] Desmond E. Williams,et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] D. Rolla,et al. Left ventricular hypertrophy in nondiabetic predialysis CKD. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] S. Derose,et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] Mark D. Huffman,et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.
[24] G. Cerasola,et al. Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. , 2007, Clinical nephrology.
[25] R. Sacco,et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community , 1994, Neurology.
[26] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[27] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[28] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[29] K. Lemley,et al. Determinants of glomerular hypofiltration in aging humans. , 2003, Kidney international.
[30] Stephen W. Sorensen,et al. Lifetime risk for diabetes mellitus in the United States. , 2003, JAMA.
[31] Desmond E. Williams,et al. Medical costs of CKD in the Medicare population. , 2013, Journal of the American Society of Nephrology : JASN.